Skip to main content
Premium Trial:

Request an Annual Quote

InBios International Gets FDA Emergency Use Authorization for SARS-CoV-2 Kit

NEW YORK – Infectious disease diagnostic firm InBios International announced Wednesday its Smart Detect SARS-CoV-2 rRT-PCR Kit has received Emergency Use Authorization from the US Food and Drug Administration.

The real-time RT-PCR test detects SARS-CoV-2 nucleic acid in nasopharyngeal, anterior nasal, and mid-turbinate nasal swabs and delivers results in about four hours, the Seattle-based company said. The test has been validated on Thermo Fisher Scientific's Applied Biosystems 7500 Fast Dx Real-Time PCR instrument and Bio-Rad Laboratories' CFX96 Touch Real-Time PCR Detection system. 

The RT-PCR test is available immediately, and InBios said it is planning to launch more tests in the next few weeks, including a serology kit for antibody detection of SARS-CoV-2.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.